Genetic tests based on the RT-PCR reaction in the diagnostics of SARS-CoV-2 infection

Przegl Epidemiol. 2021;75(1):14-26. doi: 10.32394/pe.75.02.

Abstract

Introduction: Since the SARS-CoV-2 emergence in 2019/2020, at least 158 million infections with this pathogen have been recorded, of which 3.29 million infected people have died. Due to the non-specific symptoms of SARS-CoV-2 infection, laboratory tests based on RT-PCR (reverse transcription and polymerase chain reaction) are mainly used in the diagnosis of COVID-19 disease.

Aim: The aim of this study is to compare the molecular tests available on the Polish market for the diagnosis of SARS-CoV2 infection.

Results: Based on the data provided by the manufacturers and the performed laboratory analyses, we have shown that the available diagnostic kits differ mainly in the sensitivity and duration of the reaction.

Conclusion: Due to the ongoing COVID-19 pandemic, the indicated parameters are key to effective control of the spread of SARS-CoV2, and therefore should be mainly taken into account when choosing and purchasing by diagnostic centres.

Keywords: RT-PCR; SARS-CoV-2; diagnostic tests; efficacy.

Publication types

  • Comparative Study

MeSH terms

  • COVID-19 / diagnosis*
  • Humans
  • Molecular Diagnostic Techniques / methods*
  • Molecular Diagnostic Techniques / standards*
  • Poland
  • Reverse Transcriptase Polymerase Chain Reaction / methods*
  • Reverse Transcriptase Polymerase Chain Reaction / standards*
  • SARS-CoV-2 / genetics*
  • SARS-CoV-2 / isolation & purification*
  • Sensitivity and Specificity
  • Viral Load*